Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair-deficient tumors.

Autor: Dempsey KM; 1] Department of Clinical Cancer Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA [2] Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA [3] The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA., Broaddus R; 1] The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA [2] Department of Pathology Administration, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., You YN; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Noblin SJ; 1] The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA [2] Department of Obstetrics and Gynecology, The University of Texas Health Science Center at Houston, Houston, Texas, USA [3] Department of Pediatrics, University of Texas Health Science Center at Houston, Houston, Texas, USA., Mork M; 1] Department of Clinical Cancer Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA [2] Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fellman B; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Urbauer D; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daniels M; 1] Department of Clinical Cancer Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA [2] Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA [3] The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA [4] Department of Pediatrics, University of Texas Health Science Center at Houston, Houston, Texas, USA., Lu K; 1] Department of Clinical Cancer Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA [2] The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA.
Jazyk: angličtina
Zdroj: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2015 Jun; Vol. 17 (6), pp. 476-84. Date of Electronic Publication: 2014 Oct 23.
DOI: 10.1038/gim.2014.131
Abstrakt: Purpose: Mismatch repair-deficient (MMRD) colorectal cancer (CRC) and endometrial cancer (EC) may be suggestive of Lynch syndrome (LS). LS can be confirmed only by positive germ-line testing. It is unclear if individuals with MMRD tumors but no identifiable cause (MMRD+/germ-line-) have LS. Because LS is hereditary, individuals with LS are expected to have family histories of LS-related tumors. Our study compared the family histories of MMRD+/germ-line- CRC and/or EC patients with LS CRC and/or EC patients.
Methods: A total of 253 individuals with an MMRD CRC or EC from one institution were included for analysis in one of four groups: LS; MMRD+/germ-line-; MMRD tumor with variant of uncertain significance (MMRD+/VUS); and sporadic MSI-H (MMRD tumor with MLH1 promoter hypermethylation or BRAF mutation). Family histories were analyzed utilizing MMRpro and PREMM1,2,6. Kruskal-Wallis tests were used to compare family history scores.
Results: MMRD+/germ-line- individuals had significantly lower median family history scores (MMRpro = 8.1, PREMM1,2,6 = 7.3) than did LS individuals (MMRpro = 89.8, PREMM1,2,6 = 26.1, P < 0.0001).
Conclusion: MMRD+/germ-line- individuals have less suggestive family histories of LS than individuals with LS. These results imply that MMRD+/germ-line- individuals may not all have LS. This finding highlights the need to determine other causes of MMRD tumors so that these patients and their families can be accurately counseled regarding screening and management.Genet Med 17 6, 476-484.
Databáze: MEDLINE
Externí odkaz: